The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The Cybersecurity and Infrastructure Security Agency and Food and Drug Administration Jan. 30 released notices warning of ...
On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...
President Donald Trump’s order aimed at limiting services for transgender youth could cut off federal funding but it’s ...
Three chocolate products have been recalled due to the presence of an undeclared allergen, the Food and Drug Administration ...
Nuts are full of protein, some have more than an egg. Here, dietitians share ones with the most protein and nutrients to add ...
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...